Search
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 421 - 435 of 528 items.
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Myositis
AlertHealth professional risk communication | 2019-03-13
Multiple Losartan-containing drugs voluntarily recalled because of potential for nitrosamine impurity
AlertInformation update | 2019-03-09
Homeopathic remedies are not a substitute for vaccines
AlertInformation update | 2019-03-06
Bedbugs: Don't bring them back from your vacation
AlertInformation update | 2019-03-05
Health Canada recommends that children and youth not use cough and cold products that contain opioids
AlertInformation update | 2019-02-18
Health Canada will be updating its safety review of breast implants
AlertInformation update | 2019-02-12
Important new safety information regarding the use of hydrochlorothiazide and the risk of non-melanoma skin cancer
AlertInformation update | 2019-01-31
LARTRUVO (olaratumab) - New clinical trial information important to prescribing decisions
AlertHealth professional risk communication | 2019-01-30
Health Canada warns that products sold by A1 Herbal Ayurvedic Clinic Ltd. may pose serious health risks
AlertPublic advisory | 2019-01-28
Unauthorized Panasilver product for children and adults may pose serious health risk
AlertPublic advisory | 2019-01-24
Health Canada encourages Canadians to report incidents involving medical devices to help strengthen patient safety
AlertInformation update | 2019-01-15
Health Canada safety review finds possible link between Fibristal and risk of liver injury
AlertInformation update | 2019-01-11
Health Canada warns consumers that Pace, promoted as an alcohol substitute, is unauthorized and may pose serious health risks
AlertPublic advisory | 2018-12-21
One lot of Equate brand Lens Care System and Multi-Purpose Solution voluntarily recalled because of a labelling error
AlertPublic advisory | 2018-12-21